Universal Brain
CA - Palo AltoBiotechnology
Focus: Universal Brain develops precision psychiatry platforms combining EEG wearables and AI to enable objective diagnosis and treatment monitoring in mental health. Early-stage biotech operating in the high-growth neurotechnology space with focus on depression and neurology.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Open Jobs
4+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Universal Brain?
AI assessmentAttractive early-stage bet for scientists or product builders willing to accept pre-clinical risk in exchange for outsized equity upside and platform-building autonomy.
Why Work Here
- Opportunity to shape an emerging precision psychiatry platform at the intersection of neuroscience, AI, and wearables—a structurally underserved market
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Neurofeedback
DepressionClinical Trials (1)
NCT06557525Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER)
Phase 1/2Help build intelligence for Universal Brain
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.